Hyperosmotic stress induces cell-dependent aggregation of α-synuclein.
Authors
Fragniere, Alexandra MC
Scott, Kirsten
Barker, Roger A
Publication Date
2019-02-19Journal Title
Sci Rep
ISSN
2045-2322
Publisher
Springer Science and Business Media LLC
Volume
9
Issue
1
Pages
2288
Language
eng
Type
Article
This Version
AM
Physical Medium
Electronic
Metadata
Show full item recordCitation
Fragniere, A. M., Stott, S. R., Fazal, S. V., Andreasen, M., Scott, K., & Barker, R. A. (2019). Hyperosmotic stress induces cell-dependent aggregation of α-synuclein.. Sci Rep, 9 (1), 2288. https://doi.org/10.1038/s41598-018-38296-7
Abstract
The aggregation of alpha-synuclein (α-syn) is a pathological feature of a number of neurodegenerative conditions, including Parkinson's disease. Genetic mutations, abnormal protein synthesis, environmental stress, and aging have all been implicated as causative factors in this process. The importance of water in the polymerisation of monomers, however, has largely been overlooked. In the present study, we highlight the role of hyperosmotic stress in inducing human α-syn to aggregate in cells in vitro, through rapid treatment of the cells with three different osmolytes: sugar, salt and alcohol. This effect is cell-dependent and not due to direct protein-osmolyte interaction, and is specific for α-syn when compared to other neurodegeneration-related proteins, such as Tau or Huntingtin. This new property of α-syn not only highlights a unique aspect of its behaviour which may have some relevance for disease states, but may also be useful as a screening test for compounds to inhibit the aggregation of α-syn in vitro.
Keywords
Animals, Benzothiazoles, Blotting, Western, Cell Death, Cell Line, Cell Survival, Electrophoresis, Polyacrylamide Gel, HEK293 Cells, Hot Temperature, Humans, Hydrogen Peroxide, L-Lactate Dehydrogenase, Mice, Osmolar Concentration, Parkinson Disease, Sodium Chloride, Sodium Dodecyl Sulfate, Urea, alpha-Synuclein
Sponsorship
Funding was by the DDPDgenes, Rosetree Trust, Wellcome Trust PhD Program for Clinicians, the Danish Council for Independent Research | Natural Sciences (FNU-11-113326), the Stem Cell Institute and Wellcome Trust-MRC funded Cambridge Stem Cell Institute and an NIHR award of a Biomedical Research Centre for Addenbrooke’s Hospital/University of Cambridge. RA Barker is an NIHR Senior Investigator.
Funder references
European Commission FP7 Collaborative projects (CP) (278871)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Department of Health (via National Institute for Health Research (NIHR)) (NF-SI-0616-10011)
Cambridge University Hospitals NHS Foundation Trust (CUH) (BRC 2012-2017)
Medical Research Council (MC_PC_12009)
Embargo Lift Date
2100-01-01
Identifiers
External DOI: https://doi.org/10.1038/s41598-018-38296-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/288180
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk